Head and Neck Cancer

PV 02 - Poster Viewing Q&A - Session 2

MO_35_2985 - The Radiation Dose Received By the Parotid Gland Stem Cell Region Based on Mid-Treatment Imaging Can Predict Patient-Reported Xerostomia

Monday, September 16
10:45 AM - 12:00 PM
Location: ASTRO Innovation Hub

The Radiation Dose Received By the Parotid Gland Stem Cell Region Based on Mid-Treatment Imaging Can Predict Patient-Reported Xerostomia
S. Ahmed1, P. Brodin2, C. Guha2, S. Kalnicki2, W. A. Tome2, R. Kabarriti2, and M. K. Garg2; 1Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, 2Department of Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY

Purpose/Objective(s): To determine whether the radiation dose to the parotid gland stem cell (SC) region is associated with long-term patient-reported xerostomia after definitive head and neck cancer (HNC) radiation therapy (RT), and whether mid-treatment dose assessment improves the association.

Materials/Methods: The SC region of the parotid gland, defined as being located next to the dorsal edge of the mandible, near the Stensen’s duct at the anterior border based on pre-clinical investigations, was delineated on CT scans with a 0.5 cm isotropic margin for 65 HNC patients that had undergone definitive RT between 2009 – 2014. Prospectively collected EORTC QLQ-H&N35 quality-of-life questionnaires with minimum 9 months follow-up were used to score xerostomia on a 4-grade scale, where grade 3 and 4 was considered severe xerostomia in this analysis. The SC regions were delineated on pre-treatment as well as mid-treatment CT scans to determine the best model for predicting xerostomia. The association between the mean dose to the spared parotid gland or SC region of the spared parotid and the risk of severe xerostomia was examined using logistic regression and receiver operating characteristics (ROC).

Results: Increasing radiation dose to either whole parotid or the SC region was associated with an increased risk of patient-reported xerostomia (p=0.003 and p=0.005). Importantly, the mid-treatment analysis showed that the dose to the SC region was more predictive of xerostomia than that of the pre-treatment or using the whole parotid dose, as per the ROC areas under the curve (AUCs) in Table 1. For every 1 Gy increase in radiation dose to the SC region evaluated at mid-treatment, we observed an 8% increase in the odds of xerostomia. We furthermore found that the parotid volume of patients with xerostomia was on average 27% reduced at mid-treatment, compared to only 15% for patients without xerostomia.

Conclusion: We found that increased radiation dose to the SC region of the spared parotid gland was associated with an increased risk of patient-reported xerostomia, especially when evaluated at mid-treatment. This supports the hypothesis that targeting the SC region reduces regenerative capacity of the gland, which is also supported by the large reduction in parotid size. These results can assist clinicians in adapting RT to optimize efficacy while improving patients’ post treatment quality-of-life. Table 1. Logistic regression models predicting patient-reported xerostomia.
OR per Gy (95% CI) p-value ROC AUC (95% CI)
Spared parotid mean dose pre-treatment 1.08 (1.03, 1.13) 0.003 0.72 (0.60, 0.85)
Spared parotid SC mean dose pre-treatment 1.07 (1.02, 1.12) 0.005 0.70 (0.57, 0.83)
Spared parotid mean dose mid-treatment 1.07 (1.01, 1.13) 0.026 0.72 (0.54, 0.90)
Spared parotid SC mean dose mid-treatment 1.08 (1.02, 1.14) 0.012 0.76 (0.60, 0.93)

Author Disclosure: S. Ahmed: None. P. Brodin: None. C. Guha: Translational Research Program, Gastrointestinal O; RTOG. S. Kalnicki: Travel Expenses; Varian Oncology Systems. Committee Member; American College of Radiology. W.A. Tome: Advisory Board; Archeus. Consultant; Archeus. Honoraria; Varian Inc. Research Grant; Chrysalis, Inc, Varian Inc. Travel Expenses; Varian Inc. Working Group for SBRT; AAPM. Patent/License Fees/Copyright; Wisconsin Alumni Research Foundation. Royalty; Wisconsin Alumni Research Foundation. R. Kabarriti: None. M.K. Garg: Speaker's Bureau; Varian, Covidien.

Sadia Ahmed, BA

Albert Einstein College of Medicine

Presentation(s):

Send Email for Sadia Ahmed


Assets

MO_35_2985 - The Radiation Dose Received By the Parotid Gland Stem Cell Region Based on Mid-Treatment Imaging Can Predict Patient-Reported Xerostomia



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for The Radiation Dose Received By the Parotid Gland Stem Cell Region Based on Mid-Treatment Imaging Can Predict Patient-Reported Xerostomia